Literature DB >> 23542400

Massive amounts of tissue factor induce fibrinogenolysis without tissue hypoperfusion in rats.

Mineji Hayakawa1, Satoshi Gando, Masahiro Ieko, Yoshinori Honma, Taeko Homma, Yuichiro Yanagida, Nobuhiko Kubota, Shinji Uegaki, Atsushi Sawamura, Hidesaku Asakura.   

Abstract

Trauma-induced tissue factor (TF) release into the systemic circulation is considered to play an important role in the development of disseminated intravascular coagulation (DIC) immediately after severe trauma. However, the relationship between TF and hyperfibrinolysis, especially fibrinogenolysis, has been unclear. A total of 18 rats were divided into three groups: (a) the control group was infused with normal saline; (b) the low-dose group was infused with 4 U/kg TF; and (c) the high-dose group was infused with 16 U/kg TF. Arterial blood was drawn immediately and 2 and 4 h after the start of TF infusion. At each sampling point, arterial blood gases, platelet counts, and coagulation variables were measured. The fibrinogen degradation products were evaluated by a Western blot analysis. Hypotension, hypoxemia, and lactic acidosis were not observed in any of the three groups. In proportion to the doses of TF, the platelet counts, coagulation, and fibrinolysis variables deteriorated in line with DIC. The α2-plasmin inhibitor levels significantly decreased in the high-dose group compared with the other groups. The amounts of fibrinogen degradation products increased in proportion to the doses of TF. The plasmin-α2-plasmin inhibitor complex level in the high-dose group increased more than that of the other groups. In conclusion, TF can induce DIC associated with fibrinolysis and fibrinogenolysis without tissue hypoperfusion. The decrease in the α2-plasmin inhibitor level and the significant increase in the plasmin level may be the two main factors underlying the pathogenesis of hyperfibrin(ogen)olysis after TF administration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542400     DOI: 10.1097/SHK.0b013e318293980d

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  11 in total

1.  Activated Protein C Drives the Hyperfibrinolysis of Acute Traumatic Coagulopathy.

Authors:  Ross A Davenport; Maria Guerreiro; Daniel Frith; Claire Rourke; Sean Platton; Mitchell Cohen; Rupert Pearse; Chris Thiemermann; Karim Brohi
Journal:  Anesthesiology       Date:  2017-01       Impact factor: 7.892

2.  Fibrinogen degradation product levels on arrival for trauma patients requiring a transfusion even without head injury.

Authors:  Youichi Yanagawa; Kouhei Ishikawa; Kei Jitsuiki; Toshihiko Yoshizawa; Yasumasa Oode; Kazuhiko Omori; Hiromichi Ohsaka
Journal:  World J Emerg Med       Date:  2017

3.  Evaluation of Prehospital Blood Products to Attenuate Acute Coagulopathy of Trauma in a Model of Severe Injury and Shock in Anesthetized Pigs.

Authors:  Sarah Watts; Giles Nordmann; Karim Brohi; Mark Midwinter; Tom Woolley; Robert Gwyther; Callie Wilson; Henrietta Poon; Emrys Kirkman
Journal:  Shock       Date:  2015-08       Impact factor: 3.454

Review 4.  Classifying types of disseminated intravascular coagulation: clinical and animal models.

Authors:  Hidesaku Asakura
Journal:  J Intensive Care       Date:  2014-03-06

Review 5.  Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock.

Authors:  Satoshi Gando; Yasuhiro Otomo
Journal:  Crit Care       Date:  2015-02-23       Impact factor: 9.097

Review 6.  Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis.

Authors:  Hidesaku Asakura; Hoyu Takahashi; Toshimasa Uchiyama; Yutaka Eguchi; Kohji Okamoto; Kazuo Kawasugi; Seiji Madoiwa; Hideo Wada
Journal:  Thromb J       Date:  2016-09-28

Review 7.  Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype.

Authors:  Mineji Hayakawa
Journal:  J Intensive Care       Date:  2017-01-31

8.  Hyperfibrinolysis in severe isolated traumatic brain injury may occur without tissue hypoperfusion: a retrospective observational multicentre study.

Authors:  Mineji Hayakawa; Kunihiko Maekawa; Shigeki Kushimoto; Hiroshi Kato; Junichi Sasaki; Hiroshi Ogura; Tetsuya Matsuoka; Toshifumi Uejima; Naoto Morimura; Hiroyasu Ishikura; Akiyoshi Hagiwara; Munekazu Takeda; Naoyuki Kaneko; Daizoh Saitoh; Daisuke Kudo; Takashi Kanemura; Takayuki Shibusawa; Shintaro Furugori; Yoshihiko Nakamura; Atsushi Shiraishi; Kiyoshi Murata; Gou Mayama; Arino Yaguchi; Shiei Kim; Osamu Takasu; Kazutaka Nishiyama
Journal:  Crit Care       Date:  2017-08-23       Impact factor: 9.097

Review 9.  The roles of activated protein C in experimental trauma models.

Authors:  Satoshi Gando; Toshihiko Mayumi; Tomohiko Ukai
Journal:  Chin J Traumatol       Date:  2018-12-11

10.  A clinically relevant and bias-controlled murine model to study acute traumatic coagulopathy.

Authors:  C Gangloff; O Grimault; M Theron; K Pichavant; H Galinat; F Mingant; Y Ozier
Journal:  Sci Rep       Date:  2018-04-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.